STOCK TITAN

ALX Oncology Holdings Inc. (ALXO) Net Income by Year

ALXO

ALX Oncology Holdings Inc. reported a net loss of $101.7M in fiscal year 2025. This represents an increase of 24.6% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters ALX Oncology Holdings Inc. has filed alongside them.

FY2025 annual
Net Income -$101.7M
YoY +24.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ALXO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Net Income-$101.7M+24.6%-$134.8M+16.1%-$160.8M-30.2%-$123.5M-47.9%-$83.5M-82.5%-$45.7M-137.7%-$19.2M-40.1%-$13.7M

ALXO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$18.0M+30.7%-$17.9M+41.7%N/A-$22.1M+27.9%-$25.9M+34.1%-$30.8M+13.6%N/A-$30.7M+39.8%-$39.4M-15.3%-$35.6M-17.9%N/A-$51.0M-44.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More ALX Oncology Holdings Inc. financials

Frequently Asked Questions

What was ALX Oncology Holdings Inc.'s net income in fiscal year 2025?

ALX Oncology Holdings Inc. reported a net loss of $101.7M in fiscal year 2025.

How fast is ALX Oncology Holdings Inc.'s net income growing?

ALX Oncology Holdings Inc. (ALXO) net income rose by 24.6% year over year, from -$134.8M to -$101.7M in fiscal year 2025.

How has ALX Oncology Holdings Inc.'s net income changed over the years?

Across the 8 fiscal years this page covers, ALX Oncology Holdings Inc. (ALXO) net income went from -$13.7M in fiscal year 2018 to -$101.7M in fiscal year 2025.

ALX Oncology Holdings Inc. (ALXO) reported -$18.0M in net income in Q2 2026. This represents an increase of 30.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ALX Oncology Holdings Inc. (ALXO) reported on that line in every period on record.